BACKGROUND: Randomized clinical trials comparing coronary artery bypass grafting
(CABG) with percutaneous coronary intervention (PCI) have largely excluded patients with …

Patients with chronic kidney disease (CKD) are at increased risk of cardiovascular disease
and death, yet little data exist regarding the comparative efficacy of coronary …

Background: Randomized trials of percutaneous coronary intervention (PCI) versus
coronary artery bypass graft (CABG) routinely exclude patients with chronic kidney disease …

OBJECTIVES This study compared contemporary outcomes following surgical versus
percutaneous coronary revascularization for multivessel coronary artery disease (MVCAD) …

Background: Early revascularization can lead to better prognosis in multivessel coronary
artery disease (CAD) patients with chronic kidney disease (CKD). However, whether …

Coronary artery disease (CAD) is the leading cause of morbidity and mortality in patients
with chronic kidney disease (CKD), but no study has yet compared the short-and long-term …

Coronary artery disease is a major cause of morbidity and mortality in the kidney transplant
population. We compared the long‐term outcomes of coronary artery bypass graft (CABG) …

Background—Although severe chronic kidney disease (CKD) is an independent predictor of
mortality among patients with coronary artery disease, the impact of mild CKD on morbidity …

Coronary atherosclerotic disease is highly prevalent in chronic kidney disease (CKD).
Although revascularization improves outcomes, procedural risks are increased in CKD, and …

Chronic kidney disease (CKD) might be an important determinant in choosing percutaneous
coronary intervention (PCI) and coronary artery bypass grafting (CABG). However, there is a …